Related Experiment Videos

Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker

B H Rovin1, L A Hebert

  • 1Department of Internal Medicine, Ohio State University Medical Center, Columbus, Ohio 43210, USA.

Kidney International
|November 30, 2007
PubMed

Insights

Diuretic monotherapy, recommended for high blood pressure, may cause kidney damage. Recent evidence suggests potential cardiovascular risks outweighing blood pressure benefits, necessitating further investigation into diuretic side effects.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Diuretic monotherapy is a standard initial treatment for hypertension.
  • Concerns exist regarding metabolic disturbances associated with diuretics, potentially increasing cardiovascular risk.
  • Thiazide diuretics are commonly used for hypertension management.

Purpose of the Study:

  • To discuss the potential nephrotoxicity of thiazide monotherapy.
  • To review recent evidence highlighting the adverse effects of diuretics.
  • To evaluate the risks versus benefits of diuretic use in hypertension.

Main Methods:

  • Literature review of recent studies on diuretic therapy.
  • Analysis of evidence regarding metabolic disturbances and nephrotoxicity.
  • Discussion of clinical implications of diuretic side effects.

Main Results:

  • New evidence suggests thiazide monotherapy may cause nephrotoxicity.
  • Diuretics can lead to metabolic disturbances that increase cardiovascular risk.
  • The benefits of blood pressure control may be offset by adverse effects.

Conclusions:

  • Thiazide monotherapy poses a risk of nephrotoxicity.
  • The 'dark side' of diuretics includes metabolic disturbances and potential kidney damage.
  • Further research is needed to fully understand and mitigate diuretic-associated risks in hypertension management.

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...